Skip to main content

Abstract

Cryotherapy has been used for years. The prospect of its use in focal therapy has spurred renewed interest in it, which in its recent evolutions enhance both the accuracy and reliability that are especially needed for focal ablation while preserving adjacent tissue. Improvements in thermoimaging monitoring and new percutaneous cryoprobes have resulted in lowering technical limitations and make cryotherapy fit for both primary localized prostate cancer treatment with intention-to-treat and salvage therapy for locally recurrent prostate cancer following radiation therapy.

With acknowledgments to Romain Haider, Damien Ambrosetti, Lisa Camus (photography credits)

Romain Haider, MD, Department of Urology, Hôpital Pasteur 2 - Centre Hospitalier Universitaire de Nice, University of Nice-Sophia-Anitpolis, 3à voie Romaine, 06000, Nice, France

Damien Ambrosetti, MD, PhD, Department of Pathology, Hôpital Pasteur 2 – Centre Hospitalier Universitaire de Nice,University of Nice-Sophia Antipolis, France

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Abbreviations

ASTRO:

American Society for Therapeutic Radiology and Oncology

BPH:

Benign prostate hyperplasia

DRE:

Digital rectal examination

EBRT:

External beam radiation therapy

ED:

Erectile dysfunction

HIFU:

High-intensity focused ultrasonography

IQR:

Interquartile range

PCa:

Prostate cancer

TRUS:

Transrectal ultrasound

US:

Ultrasound

VTP:

Vascular-targeted photodynamic therapy

References

  1. In the first generation of cryotherapy, Cooper and Lee made the first catheter (1961).

    Google Scholar 

  2. Robilotto AT, et al. Development of a tissue engineered human prostate tumor equivalent for use in the evaluation of cryoablative techniques. Technol Cancer Res Treat. 2007;6(2):81–9.

    Article  PubMed  Google Scholar 

  3. Hoffmann NE, Bischof JC. The cryobiology of cryosurgical injury. Urology. 2002;60(2 Suppl 1):40–9.

    Article  PubMed  Google Scholar 

  4. http://www.cryogenicsociety.org/resources/defining_cryogenics/joule-thomson_effect/.

  5. Tatsutani K, et al. Effect of thermal variables on frozen human primary prostatic adenocarcinoma cells. Urology. 1996;48(3):441–7.

    Article  CAS  PubMed  Google Scholar 

  6. Babaian RJ, et al. Best practice statement on cryosurgery for the treatment of localized prostate cancer. J Urol. 2008;180(5):1993–2004.

    Article  PubMed  Google Scholar 

  7. Nguyen HD, Allen BJ, Pow-Sang JM. Focal cryotherapy in the treatment of localized prostate cancer. Cancer Control Juill. 2013;20(3):177–80.

    Google Scholar 

  8. Bahn D, de Castro Abreu AL, Gill IS, et al. Focal cryotherapy for clinically unilateral, low-intermediate risk prostate cancer in 73 men with a median follow-up of 3.7 years. Eur Urol. 2012;62(1):55–63.

    Article  PubMed  Google Scholar 

  9. Durand M, Barret E, Galiano M, Rozet F, Sanchez-Salas R, Ahallal Y, et al. Focal cryoablation: a treatment option for unilateral low-risk prostate cancer. BJU Int. 2014;113(1):56–64.

    Article  PubMed  Google Scholar 

  10. Onik G, Vaughan D, Lotenfoe R, et al. The “male lumpectomy”: focal therapy for prostate cancer using cryoablation results in 48 patients with at least 2-year follow-up. Urol Oncol. 2008;26(5):500–5.

    Article  PubMed  Google Scholar 

  11. Ellis DS, Manny Jr TB, Rewcastle JC. Focal cryosurgery followed by penile rehabilitation as primary treatment for localized prostate cancer: initial results. Urology. 2007;70(6 Suppl 1):S9–15.

    Article  Google Scholar 

  12. Lambert EH, Bolte K, Masson P, Katz AE. Focal cryosurgery: encouraging health outcomes for unifocal prostate cancer. Urology. 2007;69:1117–20.

    Article  PubMed  Google Scholar 

  13. Ward JF, Jones JS. Focal cryotherapy for localized prostate cancer: a report from the national Cryo On-Line Database (COLD) Registry. BJU Int. 2012;109(11):1648–54.

    Article  PubMed  Google Scholar 

  14. Ellis DS, Manny Jr TB, Rewcastle JC. Cryoablation as primary treatment for localized prostate cancer followed by penile rehabilitation. Urology. 2007;69(2):306–10.

    Article  PubMed  Google Scholar 

  15. De Castro Abreu AL, Bahn D, Leslie S, Shoji S, Silverman P, Desai MM, et al. Salvage focal and salvage total cryoablation for locally recurrent prostate cancer after primary radiation therapy. BJU Int. 2013;112(3):298–307.

    Article  PubMed  Google Scholar 

  16. Babaian RJ, Donnelly B, Bahn D, Baust JG, Dineen M, Ellis D, et al. Best practice statement on cryosurgery for the treatment of localized prostate cancer. J Urol. 2008;180(5):1993–2004.

    Article  PubMed  Google Scholar 

  17. http://www.nice.org.uk/.

  18. Onik G, Narayan P, Vaughan D, et al. Focal “nerve-sparing” cryosurgery for treatment of primary prostate cancer: a new approach to preserving potency. Urology. 2002;60(1):109–14.

    Article  PubMed  Google Scholar 

  19. Consensus statement: guidelines for PSA following radiation therapy. American society for therapeutic radiology and oncology consensus panel. Int J Radiat Oncol Biol Phys. 1997;37(5):1035-41.

    Google Scholar 

  20. Pisters LL. Cryotherapy for prostate cancer: ready for prime time? Curr Opin Urol. 2010;20(3):218–22.

    Article  PubMed  Google Scholar 

  21. Williams SG, et al. An international multicenter study evaluating the impact of an alternative biochemical failure definition on the judgment of prostate cancer risk. Int J Radiat Oncol Biol Phys. 2006;65(2):351–7.

    Article  PubMed  Google Scholar 

  22. Villers A, McNeal JE, Freiha FS, Stamey TA. Multiple cancers in the prostate. Morphologic features of clinically recognized versus incidental tumors. Cancer. 1992;70(9):2313–8.

    Article  CAS  PubMed  Google Scholar 

  23. Mayes JM, Mouraviev V, Sun L, Tsivian M, Madden JF, Polascik TJ. Can the conventional sextant prostate biopsy accurately predict unilateral prostate cancer in low-risk, localized, prostate cancer? Urol Oncol. 2011;29(2):166–70.

    Article  PubMed  Google Scholar 

  24. Rosen RC, et al. Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res. 1999;11(6):319–26.

    Article  CAS  PubMed  Google Scholar 

  25. Barry MJ, et al. The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. J Urol. 1992;148(5):1549–57. discussion 1564.

    CAS  PubMed  Google Scholar 

  26. Clavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD, et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg. 2009;250(2):187–96.

    Article  PubMed  Google Scholar 

  27. Caso JR, et al. Complications and postoperative events after cryosurgery for prostate cancer. BJU Int. 2012;109:840–5. http://www.ncbi.nlm.nih.gov/pubmed/21883827.

  28. Eggener SE, Scardino PT, Carroll PR. Focal therapy for localized prostate cancer: a critical appraisal of rationale and modalities. J Urol. 2007;178(6):2260–7.

    Article  PubMed  Google Scholar 

  29. Barret E, Ahallal Y, Sanchez-Salas R, Galiano M, Cosset JM, Validire P, et al. Morbidity of focal therapy in the treatment of localized prostate cancer. Eur Urol. 2013;63:618–22.

    Article  CAS  PubMed  Google Scholar 

  30. Gonder MJ, Soanes WA, Smith V. Experimental prostate cryosurgery. Invest Urol. mai 1964;1:610–9.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Matthieu Durand MD .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer-Verlag France

About this chapter

Cite this chapter

Durand, M., Mahate, Z., Wijeratne, V. (2015). Focal Cryotherapy. In: Barret, E., Durand, M. (eds) Technical Aspects of Focal Therapy in Localized Prostate Cancer. Springer, Paris. https://doi.org/10.1007/978-2-8178-0484-2_11

Download citation

  • DOI: https://doi.org/10.1007/978-2-8178-0484-2_11

  • Published:

  • Publisher Name: Springer, Paris

  • Print ISBN: 978-2-8178-0483-5

  • Online ISBN: 978-2-8178-0484-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics